Protagonist Therapeutics News, Protagonist Therapeutics Quote, PTGX Quote

Protagonist Therapeutics (NQ:PTGX) Delayed: 28.93 +0.16 (0.56%)

Prev. Close

$28.77

Open

$28.85

52 Wk High

$24.52

52 Wk Low

$10.02

Day High

$29.30

Day Low

$28.43

P/E

N/A

EPS

$0.00

Volume

487,798

Jun 6, 2023 07:31 AM Protagonist Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at 2023 European Hematology Association (EHA) Congress
Jun 2, 2023 07:52 PM Form 4 Protagonist Therapeutics For: May 31 Filed by: Gupta Suneel
Jun 2, 2023 07:51 PM Form 4 Protagonist Therapeutics For: May 31 Filed by: PATEL DINESH V PH D
Jun 2, 2023 07:48 PM Form 4 Protagonist Therapeutics For: May 31 Filed by: Ali Asif
Jun 1, 2023 04:03 PM Protagonist Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
May 30, 2023 04:21 PM Form 8-K Protagonist Therapeutics For: May 25
May 25, 2023 02:05 AM Jefferies Assumes Protagonist Therapeutics (PTGX) at Buy, Sees 59% Upside
May 12, 2023 07:00 AM Protagonist Therapeutics (PTGX) Reports Positive Phase 1 Results for JNJ-2113
May 12, 2023 07:00 AM Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113
May 11, 2023 04:05 PM Protagonist Therapeutics to Participate in the JMP Securities Life Sciences Conference

Entities mentioned with PTGX